Skip to main content
TipRanks
Go Ultimate75% OFF

Danaher (DHR) Recurring Revenue

3,340 Followers

Recurring Revenue

Danaher reported recurring revenue of $5.40B in Q3 2026, up 3.8% from Q2 2026 and up 7.6% year over year. The highest value was $5.98B in Q4 2021.

Measures the portion of revenue expected to continue in the future, indicating business stability and potential for sustained growth.

$0.00$1.00B$2.00B$3.00B$4.00B$5.00B$6.00BMar 21Jun 21Sep 21Dec 21Mar 22Jun 22Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26Sep 26
Chart Insights

Recurring revenue has moved from a mid‑$4B base into a steadier ~$5B run rate with clear multi‑year growth and stronger momentum through 2025–H1‑2026; however, quarter‑to‑quarter spikes and the pronounced year‑end troughs reflect timing/seasonality (respiratory testing swings) and bioprocessing shipment timing rather than a loss of underlying demand. Management’s M&A (Masimo closed, StatLab pending) and strong FCF support durable recurring mix expansion and buybacks, but expect lumpy quarterly cadence even as core recurring growth remains intact.

DHR Recurring Revenue

PeriodRecurring Revenue
Q3 2026Sep 30, 2026$5.40B
Q2 2026Jun 30, 2026$5.20B
Q1 2026Mar 31, 2026$5.03B
Q4 2025Dec 31, 2025$5.32B
Q3 2025Sep 30, 2025$5.02B
Q2 2025Jun 30, 2025$4.97B
Q1 2025Mar 31, 2025$4.82B
Q4 2024Dec 31, 2024$5.11B
Q3 2024Sep 30, 2024$4.78B
Q2 2024Jun 30, 2024$4.69B
Q1 2024Mar 31, 2024$4.79B
Q4 2023Dec 31, 2023$2.78B
Q3 2023Sep 30, 2023$5.18B
Q2 2023Jun 30, 2023$5.34B
Q1 2023Mar 31, 2023$5.39B
Q4 2022Dec 31, 2022$3.26B
Q3 2022Sep 30, 2022$5.83B
Q2 2022Jun 30, 2022$5.89B
Q1 2022Mar 31, 2022$5.90B
Q4 2021Dec 31, 2021$5.98B
Q3 2021Sep 30, 2021$5.42B
Q2 2021Jun 30, 2021$5.32B
Q1 2021Mar 31, 2021$5.08B
Q4 2020Dec 31, 2020$4.73B
Q3 2020Sep 30, 2020$4.23B
Q2 2020Jun 30, 2020$3.81B
Q1 2020Mar 31, 2020$3.21B
Q4 2019Dec 31, 2019$1.74B
Q3 2019Sep 30, 2019$3.50B
Q2 2019Jun 30, 2019$3.61B
Q1 2019Mar 31, 2019$3.46B
Q4 2018Dec 31, 2018$1.52B
Q3 2018Sep 30, 2018$3.35B
Q2 2018Jun 30, 2018$3.49B
Q1 2018Mar 31, 2018$3.32B

Related KPIs